Oxcarbazepine
Back to searchMolecule Structure
Scientific Name
Oxcarbazepine
Description of the Drug
Oxcarbazepine is an anti-epileptic used in the treatment of partial-onset seizures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00776
http://www.drugbank.ca/drugs/DB00776
Brand Name(s)
Oxcarbazepine, Oxtellar xr, Trileptal
Company Owner(s)
Supernus Pharmaceuticals Inc, Rubicon Research Private Ltd, Sun Pharmaceutical Industries Ltd, Glasshouse Pharmaceuticals Ltd Canada, Amneal Pharmaceuticals, Ani Pharmaceuticals Inc, Glenmark Pharmaceuticals Ltd, Jubilant Cadista Pharmaceuticals Inc, Novartis Pharmaceuticals Corp, Taro Pharmaceutical Industries Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL35129 | |
| PharmGKB | PA450732 | |
| Human Metabolome Database | HMDB0014914 | |
| DrugBank | DB00776 | |
| PubChem: Thomson Pharma | 15196775 | |
| PubChem | 34312 | |
| Mcule | MCULE-9100100302 | |
| LINCS | LSM-5219 | |
| Nikkaji | J21.258J | |
| BindingDB | 34179 | |
| EPA CompTox Dashboard | DTXSID0045703 | |
| DrugCentral | 2017 | |
| ChemicalBook | CB9238172 | |
| Guide to Pharmacology | 7254 | |
| rxnorm | TRILEPTAL | OXCARBAZEPINE |
| PubChem: Drugs of the Future | 12013820 | |
| KEGG Ligand | C07492 | |
| ChEBI | 7824 | |
| ZINC | ZINC000000004724 |
